Advanced search
Publication Cover
Expert Opinion on Emerging Drugs Volume 18, 2013 - Issue 1
Submit an article Journal homepage
587
Views
11
CrossRef citations to date
0
Altmetric
Reviews

Emerging mitotic inhibitors for non-small cell carcinoma

Francesca CasaluceSecond University of Naples, Department of Clinical and Experimental Medicine, Naples, Italy
, MD,
Assunta SgambatoSecond University of Naples, Department of Clinical and Experimental Medicine, Naples, Italy
, MD,
Paolo Maione“S.G. Moscati” Hospital, Division of Medical Oncology, Città Ospedaliera, Contrada Amoretta, 83100 Avellino, Italy+39 0825 203 556; [email protected]
, MD,
Fortunato CiardielloSecond University of Naples, Department of Clinical and Experimental Medicine, Naples, Italy
, MD &
Cesare Gridelli“S.G. Moscati” Hospital, Division of Medical Oncology, Città Ospedaliera, Contrada Amoretta, 83100 Avellino, Italy+39 0825 203 556; [email protected]
, MD
Pages 97-107 | Published online: 01 Mar 2013

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

R. Ferrara, S. Pilotto, U. Peretti, M. Caccese, S. Kinspergher, L. Carbognin, N. Karachaliou, R. Rosell, G. Tortora & E. Bria. (2016) Tubulin inhibitors in non-small cell lung cancer: looking back and forward. Expert Opinion on Pharmacotherapy 17:8, pages 1113-1129.
Read now
Armando Lucero-Acuña, Justin J Jeffery, Edward R Abril, Raymond B Nagle, Roberto Guzman, Mark D Pagel & Emmanuelle J Meuillet. (2014) Nanoparticle delivery of an AKT/PDK1 inhibitor improves the therapeutic effect in pancreatic cancer. International Journal of Nanomedicine 9, pages 5653-5665.
Read now
Marina Shcherba, Yuanxin Liang, David Fernandes, Roman Perez-Soler & Haiying Cheng. (2014) Cell cycle inhibitors for the treatment of NSCLC. Expert Opinion on Pharmacotherapy 15:7, pages 991-1004.
Read now

Articles from other publishers (8)

Maria Francesca Baietti & Raj Nayan Sewduth. (2023) Novel Therapeutic Approaches Targeting Post-Translational Modifications in Lung Cancer. Pharmaceutics 15:1, pages 206.
Crossref
Haruna Ebisu, Kana Shintani, Takumi Chinen, Yoko Nagumo, Shuya Shioda, Taisei Hatanaka, Akira Sakakura, Ichiro Hayakawa, Hideo Kigoshi & Takeo Usui. (2021) Dual Inhibition of γ-Tubulin and Plk1 Induces Mitotic Cell Death. Frontiers in Pharmacology 11.
Crossref
Pan Huang, Xiangyang Le, Fei Huang, Jie Yang, Haofeng Yang, Junlong Ma, Gaoyun Hu, Qianbin Li & Zhuo Chen. (2020) Discovery of a Dual Tubulin Polymerization and Cell Division Cycle 20 Homologue Inhibitor via Structural Modification on Apcin. Journal of Medicinal Chemistry 63:9, pages 4685-4700.
Crossref
Lina Shan, Minjie Zhao, Ya Lu, Hongjuan Ning, Shuman Yang, Yonggui Song, Wenshu Chai & Xianbao Shi. (2019) CENPE promotes lung adenocarcinoma proliferation and is directly regulated by FOXM1. International Journal of Oncology.
Crossref
Jadd Shelton, Xiao Lu, Joseph A. Hollenbaugh, Jong Hyun Cho, Franck Amblard & Raymond F. Schinazi. (2016) Metabolism, Biochemical Actions, and Chemical Synthesis of Anticancer Nucleosides, Nucleotides, and Base Analogs. Chemical Reviews 116:23, pages 14379-14455.
Crossref
Stephen B. Helliwell. 2016. Mitochondrial Dysfunction in Neurodegenerative Disorders. Mitochondrial Dysfunction in Neurodegenerative Disorders 349 371 .
João G. Marques, Vítor M. Gaspar, David Markl, Elisabete C. Costa, Eugénia Gallardo & Ilídio J. Correia. (2014) Co-delivery of Sildenafil (Viagra®) and Crizotinib for Synergistic and Improved Anti-tumoral Therapy. Pharmaceutical Research 31:9, pages 2516-2528.
Crossref
Xue Xue, Matthew D. Hall, Qiang Zhang, Paul C. Wang, Michael M. Gottesman & Xing-Jie Liang. (2013) Nanoscale Drug Delivery Platforms Overcome Platinum-Based Resistance in Cancer Cells Due to Abnormal Membrane Protein Trafficking. ACS Nano 7:12, pages 10452-10464.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.